Corsano Health B.V. is a health-tech company developing, producing and marketing medically certified continuous health monitoring devices. Having been involved in the wearable industry for over 30 yrs and in the first developments of smartwatch applications for wearables, Peter Stas and Aletta Stas recognised the potential of smartwatch applications for medical purposes. Since 2014, they have been involved in the development of the first generation of health monitoring Swiss smartwatches. Since then, they have continued to be active at the forefront of medical applications for wearables and are currently enrolled in various clinical trials. The set up of the new, dedicated company Corsano enables full focus on this dynamic and growing market segment.
The Corsano brandname is derived from in corpore sano (in a healthy body).
The company achieved certification as a medical device manufacturer according to the ISO 13485 norm under the new MDR regulations in November 2021. In addition, the first product CardioWatch 287 achieved CE certification as a medical product under the new MDR regulation.
Dutch Heart Foundation awarded Corsano and RadboudMC a ~€1m development project to recognize cardiac arrest and alert emergency services (out of 15 parties). Corsano will develop a certified medical solution that can be sold in Europe and the USA to over 1M patients (includes device and subscription services). Planned clinical trials in 2nd half 2022 with up to seven academic hospitals will prepare evidence to apply for CE-MDR and FDA in 2024.
Advance healthcare by allowing continuous patient monitoring using big-data to generate insights for healthcare professionals.
Corrasano offers a real time research platform, enabled by the world’s most advanced smart bracelet for continuous monitoring of vital signs, with un-restricted access to raw data for AI and ML development. We leverage strategic partners to validate medical wearables for heart, lung, oncollogy and mental diseases.
Clinical accuracy is paramount for us. In addition to third parties’ algorithms, we run our proprietary algorithms to realize superior data accuracy. Corsano technology has been clinically validated in major academic hospitals. The bracelet is manufactured under ISO 13485 and CE-MDR compliance. The process for FDA Clearance has started.
What Differentiates Corsano Health
Device and platform EU-MDR certified, FDA 510K (expected 2023). Validated and proven with clinical trial data. QMS enables to add sensors, algorithms to Medical platform. +2 years head start.
35 years experience, ergonomic product, choice of materials, craftsmanship, battery life of 8-15 days, ergonomic and aesthetic designs that stimulate continuous wear.
Supply chain wearables, deep relationships with suppliers, Swiss quality, agility to rapidly develop next generations.
Corsano offers a real time research platform, enabled by the world’s most advanced smart bracelet for continuous monitoring of vital signs, with un-restricted access to raw data for AI and ML development. We manufacture medically accurate and reliable devices to monitor patients with health conditions, with a particular focus on cardiology and oncology. Devices have a user-friendly design that not only serves medical purposes but also that fits comfortably into patients' lives.
The bracelet monitor offers flexibility to set data collection intervals by minute, by second or 25Hz, 32Hz and 128Hz. We measure Heart Rate, RR intervals, Breathing Rate, A-Fib detection, SpO2, Core Body Temperature, ECG, Blood Pressure, Activity and Sleep.